Skip to main content

Advertisement

Log in

Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Fatigue and depression are common co-morbid conditions among people with HIV infection. We analyzed a population of HIV-infected adults with depression, who were enrolled in a depression treatment trial, to examine the extent to which improvements in depression over time were associated with improvements in HIV-related fatigue. Data for this analysis come from a randomized controlled trial to evaluate the effectiveness of improved depression treatment on antiretroviral adherence. Fatigue was measured using the HIV-Related Fatigue Scale, and depressive symptoms were measured with the Hamilton Depression Rating Scale. Participants (n = 234) were on average nearly 44 years of age and predominantly male, black or African American, and unemployed. Individuals who experienced stronger depression response (i.e., greater improvement in depression score) had larger decreases in fatigue. However, even among those who demonstrated a full depression response, nearly three-quarters continued to have either moderate or severe fatigue at 6 and 12 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Erdbeer G, Sabranski M, Sonntag I, et al. Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy. J Int AIDS Soc. 2014;17(4 Suppl 3):19673.

    PubMed Central  PubMed  Google Scholar 

  2. Jong E, Oudhoff LA, Epskamp C, et al. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS. 2010;24(10):1387–405.

    Article  CAS  PubMed  Google Scholar 

  3. Barroso J, Harmon JL, Madison JL, Pence BW. Intensity, chronicity, circumstances, and consequences of HIV-related fatigue: a longitudinal study. Clin Nurs Res. 2014;23(5):514–28.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.

    Article  CAS  PubMed  Google Scholar 

  5. Orlando M, Burnam MA, Beckman R, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11(2):75–82.

    Article  PubMed  Google Scholar 

  6. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306.

    Article  PubMed  Google Scholar 

  7. Barroso J. HIV-related fatigue. Am J Nurs. 2002;102(5):83–6.

    Article  PubMed  Google Scholar 

  8. Barroso J, Carlson JR, Meynell J. Physiological and psychological markers associated with HIV-related fatigue. Clin Nurs Res. 2003;12(1):49–68.

    Article  PubMed  Google Scholar 

  9. Barroso J, Hammill BG, Leserman J, Salahuddin N, Harmon JL, Pence BW. Physiological and psychosocial factors that predict HIV-related fatigue. AIDS Behav. 2010;14(6):1415–27.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Barroso J, Lynn MR. Psychometric properties of the HIV-Related Fatigue Scale. J Assoc Nurses AIDS Care. 2002;13(1):66–75.

    Article  PubMed  Google Scholar 

  11. Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik S. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage. 1998;15(3):159–67.

    Article  CAS  PubMed  Google Scholar 

  12. Henderson M, Safa F, Easterbrook P, Hotopf M. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy. HIV Med. 2005;6(5):347–52.

    Article  CAS  PubMed  Google Scholar 

  13. Millikin CP, Rourke SB, Halman MH, Power C. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol. 2003;25(2):201–15.

    Article  PubMed  Google Scholar 

  14. Paddison J, Fricchione G, Gandhi RT, Freudenreich O. Fatigue in psychiatric HIV patients: a pilot study of psychological correlates. Psychosomatics. 2009;50(5):455–60.

    Article  PubMed  Google Scholar 

  15. Schifitto G, Deng L, Yeh TM, et al. Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. J Neurovirol. 2011;17(1):17–25.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Voss JG. Predictors and Correlates of Fatigue in HIV/AIDS. J Pain Symptom Manage. 2005;29(2):173–84.

    Article  PubMed  Google Scholar 

  17. Jaggers JR, Hand GA, Dudgeon WD, et al. Aerobic and resistance training improves mood state among adults living with HIV. Int J Sports Med. 2015;36(2):175–81.

    CAS  PubMed  Google Scholar 

  18. Barroso J, Leserman J, Harmon JL, Hammill B, Pence BW. Fatigue in HIV-Infected people: a three-year observational study. J Pain Symptom Manage. 2015;50(1):69–79.

    Article  PubMed  Google Scholar 

  19. Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, Hand GA. Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs. 2004;6(1):59–74.

    Article  PubMed  Google Scholar 

  20. Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: APA; 2013.

    Google Scholar 

  21. Voss J, Portillo CJ, Holzemer WL, Dodd MJ. Symptoms cluster of fatigue and depression in HIV/AIDS. J Prev Interv Community. 2007;33:19–34.

    Article  PubMed  Google Scholar 

  22. Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik S. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage. 1998;15:159–67.

    Article  CAS  PubMed  Google Scholar 

  23. Rabkin JG, Wagner GJ, McElhiney MC, Rabkin R, Lin SH. Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: A placebo-controlled study. J Clin Psychopharmacol. 2004;24:379–85.

    Article  CAS  PubMed  Google Scholar 

  24. Pence BW, Gaynes BN, Williams Q, et al. Assessing the effect of measurement-based care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials. 2012;33(4):828–38.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.

    Article  CAS  PubMed  Google Scholar 

  26. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33 quiz 34–57.

    PubMed  Google Scholar 

  27. Adams JL, Gaynes BN, McGuinness T, Modi R, Willig J, Pence BW. Treating depression within the HIV “medical home”: a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDs. 2012;26(11):647–54.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Pence BW, Barroso J, Leserman J, Harmon JL, Salahuddin N. Measuring fatigue in people living with HIV/AIDS: psychometric characteristics of the HIV-related fatigue scale. AIDS Care. 2008;20(7):829–37.

    Article  CAS  PubMed  Google Scholar 

  29. Pence BW, Barroso J, Harmon JL, Leserman J, Salahuddin N, Hammill BG. Chronicity and remission of fatigue in patients with established HIV infection. AIDS Patient Care STDs. 2009;23(4):239–44.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–96.

    Article  CAS  PubMed  Google Scholar 

  31. Leucht S, Fennema H, Engel R, Kaspers-Janssen M, Lepping P, Szegedi A. What does the HAMD mean? J Affect Disord. 2013;148(2–3):243–8.

    Article  PubMed  Google Scholar 

  32. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry. 2001;62(Suppl 16):5–9.

    CAS  PubMed  Google Scholar 

  33. Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92–100.

    Article  CAS  PubMed  Google Scholar 

  34. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267–83.

    Article  CAS  PubMed  Google Scholar 

  35. Pence BW, Thielman NM, Whetten K, Ostermann J, Kumar V, Mugavero MJ. Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDs. 2008;22(11):869–77.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Shively M, Smith T, Bormann J, Gifford A. Evaluating self-efficacy for HIV disease management skills. AIDS Behav. 2002;6(4):371–9.

    Article  Google Scholar 

  37. McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31(2):180–6.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Paykel ES. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2008;10(4):431–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  39. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 2011;32(1):7–24.

    CAS  PubMed  Google Scholar 

  40. Morris G, Berk M, Walder K, Maes M. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med. 2015;13:28.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Rabkin JG, McElhiney MC, Rabkin R. Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial. Psychosomatics. 2011;52(4):328–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Kudel I, Cotton S, Szaflarski M, Holmes WC, Tsevat J. Spirituality and religiosity in patients with HIV: a test and expansion of a model. Ann Behav Med. 2011;41(1):92–103.

    Article  PubMed  Google Scholar 

Download references

Author contributions

Study concept and design: Barroso, Gaynes, Quinlivan, Heine, Thielman, Pence. Statistical analysis: Bengtson, Pence. Drafting of the manuscript: Barroso, Bengtson, Pence. Critical revision of the manuscript for important intellectual content: All authors. The senior author (BWP) had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julie Barroso.

Ethics declarations

Conflicts of interest

The authors report no conflicts of interest.

Funding/Support

This work was supported by grant R01-MH086362 from the National Institute of Mental Health and the National Institute for Nursing Research, National Institutes of Health, Bethesda, MD, USA. Support for the design and conduct of the study was also provided by the NIH-funded Centers for AIDS Research at the University of North Carolina at Chapel Hill, Duke University, and the University of Alabama at Birmingham (P30-AI50410, P30-AI064518, and P30-AI027767). AB was also supported by T32-AI007001 of the NIH.

Additional information

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barroso, J., Bengtson, A.M., Gaynes, B.N. et al. Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial. AIDS Behav 20, 235–242 (2016). https://doi.org/10.1007/s10461-015-1242-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-015-1242-4

Keywords

Navigation